PRAME Cell Therapy: Global, randomized, controlled Phase 3 trial, SUPRAME, in previously treated advanced melanoma ongoing; anzu-cel received Orphan Drug Designation from the FDA for the treatment of ...
Bayer Aktiengesellschaft ( BAYRY) Q4 2025 Earnings Call March 4, 2026 8:00 AM EST ...
Q4 2025 Earnings Call March 4, 2026 8:30 AM ESTCompany ParticipantsJim Floros - Vice President of Investor RelationsMike Greenley ...
The Law on the Administration of Activities of International Non-Governmental Organizations in the People’s Republic of China (the INGO Law) stipulates that ‘international non-governmental ...
Maple Leaf Foods Inc. ("Maple Leaf Foods" or "the Company") today reported its financial results for the fourth quarter and ...
TSX: MFI Maple Leaf Foods reports fourth quarter Revenue growth of 8.1% and Adjusted EBITDA growth of 8.3% MISSISSAUGA, ON, March 5, 2026 /PRNewswire/ - Maple Leaf ...
StubHub Holdings, Inc. ("StubHub" or the "Company"), a leading global ticketing marketplace for live events, today reported financial results for the fourth quarter and full year ended December 31, ...
Fourth Quarter 2025 Highlights; Total Revenue of $36.5 million, up 3% from prior year. Annual Recurring Revenue ("ARR") ...
Okta, Inc. (Nasdaq: OKTA), the leading independent identity partner, today announced financial results for its fourth quarter ...
BOWLING GREEN, Ky., March 04, 2026 (GLOBE NEWSWIRE) -- Holley Performance Brands (NYSE: HLLY), a leader in automotive aftermarket performance solutions, today announced financial results for its ...
Paramount Skydance plans to redevelop its historic Hollywood studio as it consolidates the vast Warner Bros. and Paramount ...